Color’s genetic testing platform is built on a robust, clinical-grade next-generation sequencing (NGS) infrastructure, optimized for accuracy, scalability, and affordability.

We recommend that you share your Color test results with your healthcare provider. This can help you and your provider create a personalized healthcare plan. If you don’t have your own healthcare …

Medications listed here could be impacted by specific genetic results, according to FDA drug labels, or the Clinical Pharmacogenetics Implementation Consortium (CPIC) www.fda.gov/medical …

Discover comprehensive genetic insights and personalized health solutions from Color, empowering informed decisions in oncology, pharmacogenomics, and preventive care.

Does it matter for me? The CYP2C cluster influences how quickly the body processes certain medications used to prevent blood clots.

Color uses and discloses PHI in a number of ways connected to your treatment, payment for your care, and our healthcare operations. Some examples of how we may use or disclose your PHI that do not …

This document describes the development and validation of the Color HPV Test, a laboratory developed test (LDT) that detects hrHPV in first-void urine.

Does it matter for me? The VKORC1 gene influences how quickly the body processes certain medications that are used to prevent blood clots.

Color uses next generation sequencing (NGS) and custom bioinformatics pipelines to analyze genes related to hereditary cancer risk and medication response. DNA is extracted from the sample and …

For a complete list of gene-phenotype associations please visit: color.com/learn/color-genes. All classifications are evaluated by a board certified medical geneticist or pathologist.